T

TetraScience

Cloud-native platform centralizing scientific data

Overview

TetraScience offers a cloud-based Scientific Data Cloud that helps biopharmaceutical teams collect, centralize, and harmonize scientific data from lab instruments, software, and apps. It connects data across R&D, QA/QC, and manufacturing so data workflows run faster and data is ready for AI/ML analyses. The platform is vendor-neutral and open, designed to work with any lab equipment or software, providing end-to-end data management across the biopharma value chain. Its goal is to improve scientific outcomes by turning scattered data into a unified, ready-to-use data foundation that accelerates data-driven discovery and production.

YC Company

Work here?Claim your company

About TetraScience

Simplify's Rating
Why TetraScience is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareAI & Machine LearningBiotechnology

Company Size

201-500

Company Stage

Series B

Total Funding

$117.2M

Headquarters

Boston, MA

Founded

2019

Get referred to TetraScience

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • November 5, 2026 updates show Takeda expanding Tetra data usage across R&D.
  • August 2025 Tetra Workflows automates lab processes, increasing switching costs and usage depth.
  • January 2026 Microsoft collaboration widens distribution and strengthens Azure-based enterprise buying credibility.

What critics are saying

  • Sales depend on deep integrations that customers can replace with Databricks or Snowflake stacks.
  • Top-down platform bets invite budget delays if Takeda, Bayer, or Syngenta slow rollouts.
  • If one large pharma cancels, TetraScience's services-heavy model loses credibility and revenue quickly.

What makes TetraScience unique

  • TetraScience's Tetra OS standardizes scientific data across instruments, apps, and CROs.
  • January 2026 Matt Studney joined from Merck, validating enterprise-grade scientific platform adoption.
  • April 2026 Syngenta chose Tetra OS, proving crop-science expansion beyond pharma.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$117.2M

Above

Industry Average

Funded Over

7 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Above Average

Industry standards

$35M
$45M
$65M
$80M
$100M

Benefits

  • Unlimited PTO
  • 100% company paid health, dental, & vision
  • Company paid life insurance
  • 401k savings
  • Company paid disability insurance
  • Equity program
  • Flexible work arrangements

Growth & Insights and Company News

6 month growth

0%

1 year growth

1%

2 year growth

-1%
PR Newswire
Jan 15th, 2026
TetraScience Appoints Matt Studney as Chief Customer Officer, Signaling Industry Shift Toward Platform-Based Scientific AI

TetraScience appoints Matt Studney as Chief Customer Officer, signaling industry shift toward platform-based Scientific AI. News provided by. 24-Year Merck Veteran and Former SVP of R&D IT Joins TetraScience to Help Industrialize Scientific Data and AI Across Biopharma BOSTON, Jan. 15, 2026 /PRNewswire/ - TetraScience, the Scientific Data and AI company, today announced the appointment of Matt Studney as Chief Customer Officer. Studney is a seasoned business, R&D, and technology leader with more than two decades of experience operating at the intersection of science, data, and engineering. Most recently, Studney served as Senior Vice President of R&D IT and Key Partnerships at Merck, where he led large-scale modernization of scientific, laboratory, and development platforms and helped scale data, cloud, and AI capabilities across the full R&D continuum. His work enabled faster scientific decision-making, improved reproducibility, and more resilient digital foundations for over 18,000 scientists and researchers worldwide. Studney's decision to join TetraScience reflects a broader inflection point in the biopharma industry. As scientific complexity accelerates and AI becomes central to competitive advantage, platform-based approaches to scientific data and AI are increasingly replacing bespoke, project-driven solutions across discovery, development and manufacturing. "Matt has lived firsthand the limits of artisanal approaches to scientific data and AI," said Patrick Grady, Co-Founder and CEO of TetraScience. "His move to TetraScience signals that the center of gravity is shifting - from bespoke internal efforts toward shared platforms purpose-built to make scientific intelligence durable, cumulative, and scalable." "Matt is a world-class operational leader with unparalleled credibility and relationships within the pharmaceutical industry, and his appointment represents a safe and trusted choice for pharmaceutical companies looking to partner with TetraScience on their scientific data and AI transformation journeys," added Grady. At Merck, Studney designed, established and governed strategic partnerships with AWS, Accenture, Veeva, NVIDIA, BCG X, and QuantumBlack, while overseeing modernization across lab, clinical, and manufacturing technologies. His initiatives helped reduce discovery cycle times by 33%, accelerate regulatory submissions by up to four weeks, and deliver more than $100 million in savings within the first six months of a multi-year optimization program. "Over the course of my career in one of the world's most complex pharmaceutical organizations, I've seen firsthand what works - and what breaks - when you try to scale scientific intelligence inside global pharma," said Studney. "The AI era makes clear that true transformation now requires a fundamentally new architectural foundation. Scientific intelligence cannot scale on fragmented data or bespoke workflows. TetraScience has built the platform needed to industrialize scientific data and make learning cumulative across the enterprise. Patrick's long-standing vision for Scientific AI, combined with the company's deep technical and scientific capabilities, makes clear that TetraScience is the natural steward of this next phase of the industry." Studney is a recognized industry voice across global technology and biopharma leadership forums, advising organizations on AI enablement, platform strategy, and partnership governance. At TetraScience, he will partner closely with biopharma customers to help them move beyond project-by-project modernization toward a shared scientific data and AI platform, working side-by-side through the organizational and operational change this transition requires. Through TetraScience's Sciborg model, his mandate is to translate platform architecture into durable adoption and measurable scientific, operational, and economic outcomes across discovery, development, and manufacturing. About TetraScience TetraScience is the Scientific Data and AI Company building Tetra OS, the operating system for scientific intelligence. Tetra OS integrates the Scientific Data Foundry, Scientific Use Case Factory, Tetra AI, and Sciborgs into a single, AI-native platform. Together, these capabilities turn fragmented scientific data and workflows into governed, reusable, and compounding intelligence across discovery, development, and manufacturing. TetraScience is trusted by leading biopharma organizations and ecosystem partners including NVIDIA, Databricks, Snowflake, Google, and Microsoft. For more information, visit tetrascience.com.

Yahoo Finance
Aug 13th, 2025
TetraScience Launches Tetra Workflows to Automate Scientific Data Workflows at Scale

BOSTON, Aug. 13, 2025 /PRNewswire/ - TetraScience, the Scientific Data and AI Cloud company, today announced the launch of Tetra Workflows, a comprehensive solution that fundamentally transforms how laboratories manage and automate scientific data workflows at scale.

BioSpace
Jan 16th, 2025
TetraScience Collaborates with Microsoft To Advance Scientific AI at Scale

TetraScience collaborates with Microsoft to advance Scientific AI at scale.

HIT Consultant
Jan 16th, 2025
Tetrascience & Microsoft Partner To Advance Scientific Ai In Biopharma

What You Should Know: – TetraScience, a provider of scientific data cloud solutions announced a strategic collaboration with Microsoft to accelerate the adoption of artificial intelligence (AI) in the biopharmaceutical industry. – The strategic partnership combines TetraScience’s Scientific Data and AI Cloud with the power and security of Microsoft Azure, creating a robust platform for scientific organizations to extract valuable insights from their complex experimental data.Explosion of Scientific Data ChallengesThe biopharmaceutical industry is facing a critical challenge: the explosion of scientific data. While AI holds immense promise for accelerating drug discovery and development, much of this data remains trapped in proprietary formats and scattered across disparate systems. This hinders the effective training and deployment of AI models, limiting the potential for breakthroughs.Harmonizing Scientific Data and Empowering AI WorkflowsThe TetraScience and Microsoft collaboration addresses this challenge head-on. By providing a comprehensive solution that encompasses massive computational power, advanced AI models, sophisticated scientific data ontologies, and deep scientific expertise, the partnership empowers organizations to overcome data silos and unlock the full potential of AI.TetraScience’s Scientific Data and AI Cloud is purpose-built to replatform and engineer scientific data into powerful data models and domain-specific use cases. This harmonizes data from hundreds of scientific instruments and vendor formats, ensuring that experimental context is preserved for multimodal analytics and AI model training.Microsoft Azure provides the enterprise-grade infrastructure and computational backbone for demanding scientific workloads, including real-time analytics and large-scale AI applications. This ensures that researchers have the resources they need to train and deploy sophisticated AI models.Preliminary Collaboration ResultsThis collaboration is already delivering tangible results

NVIDIA
Nov 13th, 2024
Japan Develops Next-Generation Drug Design, Healthcare Robotics and Digital Health Platforms

At AI Summit Japan, TetraScience, a company that engineers AI-native scientific datasets, announced a collaboration with NVIDIA to industrialize the production of scientific AI use cases to accelerate and improve workflows across the life sciences value chain.

Recently Posted Jobs

Sign up to get curated job recommendations

TetraScience is Hiring for 18 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs